XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Report
- Report Number
- 2024168-2010-02432
- Event Type
- Death
- Date Received
- November 12, 2010
- Date of Event
- September 10, 2010
- Report Date
- October 20, 2010
- Manufacturer
- ABBOTT VASCULAR-CARDIAC THERAPIES
- Product Code
- NIQ
- PMA / PMN Number
- P070015
- Removal / Correction Number
- NA
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- AL, US
- Reporter Occupation
- PHYSICIAN
Narratives
(B)(4). THERE WAS NO REPORTED PRODUCT DEFICIENCY. DEATH IS A KNOWN ADVERSE EVENT AS LISTED IN THE XIENCE V INSTRUCTIONS FOR USE. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECT AND THE RELATIONSHIP TO THE DEVICE, IF ANY, CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE, DESIGN, OR LABELING. REPORTEDLY, DIRECT STENTING WAS PERFORMED. IT SHOULD BE NOTED THAT THE IFU CAUTIONS THAT THE VESSEL SHOULD BE PRE-DILATED WITH AN APPROPRIATE SIZED BALLOON. FAILURE TO DO SO MAY INCREASE THE DIFFICULTY OF STENT PLACEMENT AND CAUSE PROCEDURAL COMPLICATIONS.
IT WAS REPORTED VIA TRIAL THAT APPROXIMATELY 2 YEARS POST DIRECT STENTING OF TWO XIENCE STENTS, ONE IN THE PROXIMAL 1ST OBTUSE MARGINAL ARTERY (P 1STOM), AND ON IN THE MID RIGHT CORONARY ARTERY (MRCA), THE PATIENT DIED. THE PATIENT WAS BEING CONTACTED FOR THEIR 2 YEAR FOLLOW UP. PER A FAMILY MEMBER, THE PATIENT DID IN THEIR SLEEP. CAUSE OF DEATH IS UNK. ALTHOUGH REQUESTED THERE WAS NO ADDITIONAL INFORMATION PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM | NIQ | ABBOTT VASCULAR-CARDIAC THERAPIES | NA | 8061161 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 58 YR | Death | ASPIRIN| SERIAL #(B)(4))| STENT: XIENCE V ((B)(4), LOT #7110561,| OTHER: CLOPIDOGREL, |